Clin Mol Hepatol.
2023 Feb;29(Suppl):S220-S227. 10.3350/cmh.2022.0360.
Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
- Affiliations
-
- 1Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea
- KMID: 2539803
- DOI: http://doi.org/10.3350/cmh.2022.0360
Abstract
- The incidence of hepatocellular carcinoma (HCC) associated with nonalcoholic fatty liver disease (NAFLD) has been increasing worldwide, including Asia. Most patients with NAFLD-related HCC are at a much-advanced stage and older age at the time of diagnosis than those with virus-related HCC because they have not undergone HCC surveillance. This review provides an overview of the mechanism of hepatocarcinogenesis in NAFLD, preventive strategies for NAFLDrelated HCC, and strategies for the surveillance of patients with NAFLD.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
- Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
- Epidemiology of Nonalcoholic Fatty Liver Disease
- Nonalcoholic Fatty Liver Disease in Children
- Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
